Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
45.1M
-
Number of holders
-
96
-
Total 13F shares, excl. options
-
38.7M
-
Shares change
-
-6.3M
-
Total reported value, excl. options
-
$134M
-
Value change
-
-$121M
-
Put/Call ratio
-
0.3
-
Number of buys
-
64
-
Number of sells
-
-40
-
Price
-
$3.47
Significant Holders of THIRD HARMONIC BIO, INC. - Common Stock, par value $0.0001 per share (THRD) as of Q1 2025
126 filings reported holding THRD - THIRD HARMONIC BIO, INC. - Common Stock, par value $0.0001 per share as of Q1 2025.
THIRD HARMONIC BIO, INC. - Common Stock, par value $0.0001 per share (THRD) has 96 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38.7M shares
of 45.1M outstanding shares and own 85.93% of the company stock.
Largest 10 shareholders include Atlas Venture Life Science Advisors, LLC (10.4M shares), ORBIMED ADVISORS LLC (5.78M shares), BML Capital Management, LLC (3.82M shares), Nantahala Capital Management, LLC (2.94M shares), TCG Crossover Management, LLC (2.51M shares), BVF INC/IL (2.37M shares), BlackRock, Inc. (1.48M shares), VANGUARD GROUP INC (1.16M shares), TANG CAPITAL MANAGEMENT LLC (930K shares), and Newtyn Management, LLC (635K shares).
This table shows the top 96 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.